INSP Inspire Medical Systems, Inc.
Last updated: Nov 16, 2026
Execution Consistency
Did the company actually spend money buying back stock in 3+ of the last 4 quarters?
Bought back stock in 2/4 quarters. Q3 2026: $50M, Q2 2026: $0M, Q1 2026: $75M, Q3 2025: $0M
Execution Acceleration
Is the most recent quarter's buyback spend more than 15% above the trailing average?
Latest quarter $50M vs trailing avg $25M (+100%)
Buyback vs FCF
What percentage of free cash flow is going to buybacks? Bull: 30%+. Bear: negative FCF or no buybacks.
Negative FCF ($-114M), buybacks not supported by cash flow
Buyback Intensity
How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.
Repurchased 0 shares = 0.0% of 28,579,015 outstanding (annualized)
Insider Buying
Are officers and directors buying stock with their own money on the open market?
2 open-market purchases by 1 insiders
- Curet Myriam () bought 1 shares at $148.26 on 2025-04-07
- Curet Myriam () bought 4 shares at $163.84 on 2025-03-20
Insider-Buyback Convergence
Are both company buybacks and insider buying independently active? Bull when the company is buying back stock in 2+ quarters and insiders have made 2+ open-market purchases.
Company buybacks in 2 quarters and 2 insider purchases by 1 insiders (overlapped in 2 quarters)
- Q3 2026: Curet Myriam bought while company spent $50M
- Q1 2026: Curet Myriam bought while company spent $75M
Insider Net Direction
Over the last 90 days, are insiders net buyers or net sellers on the open market?
Insiders bought $0M, sold $0M in the last 90 days (net selling)
Red Flag
Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.
Company buying back stock while insiders sold 829.5x more than bought